Having trouble accessing articles? Reset your cache.

TB-403: Phase I/IIa started

Oncurious and BioInvent began an open-label, U.S. Phase I/IIa of IV TB-403 in >=27

Read the full 149 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE